Industry Analysis & Industry Trends
The Biotechnology industry investigates and capitalises on the commercial applications of biological manipulation. It is fast becoming a prominent part of the UK life sciences scene alongside pharmaceutical and medical technology firms. The convergence of these three technologies is making it increasingly difficult to identify the boundaries between them. The industry relies on third-party financing, so the economic downturn posed significant funding challenges during many years of the period. This dampened growth, but could not contain it. Britain's ageing, ailing population requires advanced treatment options to ward off natural bodily decline and the Biotechnology industry has managed to attract relatively high levels of private investment to research this area... purchase to read more
Industry Report - Industry Key Buyers Chapter
The industry is comprised predominantly of small and medium-size enterprises. According to a joint study published in 2011 by the Department of Health, UK Trade & Investment and the Department of Business, Innovation and Skills, 98% of all medical biotechnology companies are small or medium-size enterprises with fewer than 250 employees.
Fewer than half of all firms in the industry are more than 10 years old and just over 40% are between four and nine years old. There is some fluctuation on these figures across product segments, but most companies, like the industry itself, are relatively young. They are also fairly small and even the largest UK-based firms tend to be modest operations. Most are happy to stay lean and focus on a limited number of products... purchase to read more